(-)-Huperzine A structure
|
Common Name | (-)-Huperzine A | ||
|---|---|---|---|---|
| CAS Number | 102518-79-6 | Molecular Weight | 242.32 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 479.5±25.0 °C at 760 mmHg | |
| Molecular Formula | C15H18N2O | Melting Point | 211-216oC | |
| MSDS | Chinese USA | Flash Point | 243.8±23.2 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of (-)-Huperzine AHuperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value:Target: AChEHuperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. Huperzine A is a potential therapeutic agent for Alzheimer's disease. |
| Name | huperzine A |
|---|---|
| Synonym | More Synonyms |
| Description | Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value:Target: AChEHuperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. Huperzine A is a potential therapeutic agent for Alzheimer's disease. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 479.5±25.0 °C at 760 mmHg |
| Melting Point | 211-216oC |
| Molecular Formula | C15H18N2O |
| Molecular Weight | 242.32 |
| Flash Point | 243.8±23.2 °C |
| PSA | 58.88000 |
| LogP | -0.22 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.741 |
| Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300 + H310 + H330-H315-H319-H335 |
| Precautionary Statements | P260-P264-P280-P284-P301 + P310-P302 + P350 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T+ |
| Risk Phrases | R26/27/28;R36/37/38 |
| Safety Phrases | 26-36/37/39-45 |
| RIDADR | UN 1544 6.1/PG 2 |
| WGK Germany | 3 |
| RTECS | PB9185700 |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
An efficient total synthesis of (-)-huperzine A.
Org. Lett. 14(17) , 4446-9, (2012) The total synthesis of Lycopodium alkaloid (-)-huperzine A has been accomplished in 10 steps with 17% overall yield from commercially abundant (R)-pulegone. The synthetic route features an efficient s... |
|
|
Induction of human CYP3A4 by huperzine A, ligustrazine and oridonin through pregnane X receptor-mediated pathways.
Pharmazie 69(7) , 532-6, (2014) The pregnane X receptor (PXR) is a key regulator of CYP3A4, which is involved in catalyzing the metabolic conversion of a number of endogenous substrates. In this study, we screened 22 compounds isola... |
|
|
Simultaneously preparative purification of Huperzine A and Huperzine B from Huperzia serrata by macroporous resin and preparative high performance liquid chromatography.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 904 , 65-72, (2012) Huperzine A (HupA) and Huperzine B (HupB) are natural alkaloids existed in Lycopodium plants. They both have potential clinical application for treating Alzheimer's Disease (AD). For the purpose of be... |
| 5-Amino-1,2-dihydro-3H-pyrazol-3-one |
| (−)-Huperzine A |
| MFCD01714949 |
| (−)-Selagine |
| (-)-Huperzine A |
| 3-Amino-5-pyrazolone |
| 3-Amino-1H-pyrazol-5-ol |
| 3H-Pyrazol-3-one, 5-amino-1,2-dihydro- |
| Huperzine A |